Cargando…
Serum von Willebrand factor for early diagnosis of lung adenocarcinoma in patients with type 2 diabetes mellitus
BACKGROUND: The elevation of plasma von Willebrand factor (vWF) has been proposed to be a predictor of lung cancer. Type 2 diabetes mellitus (T2DM) causes endothelial activation, resulting in the secretion of vWF. However, the role of vWF in patients with T2DM complicated with lung cancer remains un...
Autores principales: | Zhou, Ying-Yi, Du, Xuan, Tang, Jia-Li, Wang, Qiu-Ping, Chen, Ke, Shi, Bi-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262717/ https://www.ncbi.nlm.nih.gov/pubmed/32518781 http://dx.doi.org/10.12998/wjcc.v8.i10.1916 |
Ejemplares similares
-
ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
por: Takaya, Hiroaki, et al.
Publicado: (2019) -
Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases
por: Cibor, Dorota, et al.
Publicado: (2017) -
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022) -
Role of von Willebrand factor in the angiogenesis of lung adenocarcinoma
por: Li, Xin, et al.
Publicado: (2022) -
Clinical value evaluation of serum markers for early diagnosis of colorectal cancer
por: Song, Wen-Yue, et al.
Publicado: (2020)